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The hepatic immune system can induce rapid and controlled responses to pathogenic
microorganisms and tumor cells. Accordingly, most of the microorganisms that reach
the liver through the blood are eliminated. However, some of them, including Brucella
spp., take advantage of the immunotolerant capacity of the liver to persist in the host.
Brucella has a predilection for surviving in the reticuloendothelial system, with the liver
being the largest organ of this system in the human body. Therefore, its involvement
in brucellosis is practically invariable. In patients with active brucellosis, the liver is
commonly affected, and the most frequent clinical manifestation is hepatosplenomegaly.
The molecular mechanisms implicated in liver damage have been recently elucidated.
It has been demonstrated how Brucella interacts with hepatocytes inducing its death
by apoptosis. The inflammatory microenvironment and the direct effect of Brucella on
hepatic stellate cells (HSC) induce their activation and turn these cells from its quiescent
form to their fibrogenic phenotype. This HSC activation induced by Brucella infection
relies on the presence of a functional type IV secretion system and the effector protein
BPE005 through a mechanism involved in the activation of the autophagic pathway.
Finally, the molecular mechanisms of liver brucellosis observed so far are shedding light
on how the interaction of Brucella with liver cells may play an important role in the
discovery of new targets to control the infection. In this review, we report the current
understanding of the interaction between liver structural cells and immune system cells
during Brucella infection.
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BRUCELLOSIS
Brucellosis is a common zoonotic disease distributed around the world. The disease is rare
in industrialized countries because of the routine screening of domestic livestock and animal
vaccination program (Pappas et al., 2006; Mancini et al., 2014). Recently, case studies and
review of published cases have been carried out to determine the prevalence of brucellosis
in endemic regions. However, it should be borne in mind that because many areas with
endemic brucellosis have poor infrastructure, it is likely that the incidence of the disease is
underestimated. There are a reported 500,000 incident cases of human brucellosis per year.
However, true incidence is estimated to be 5,000,000 to 12,500,000 cases annually (Godfroid
et al., 2013; Hull and Schumaker, 2018). The clinical disease is common in the Middle
East, Asia, Africa, South and Central America, the Mediterranean Basin, and the Caribbean
(Pappas et al., 2006; Mancini et al., 2014; Cross et al., 2019).
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At present, 12 species of Brucella genus have been described,
each of which has its natural host, including domestic and
farm animals, as well as wild animals, such as camels, bison,
foxes, cetaceans, among others. Brucella is an expanding genus,
and the most recent species were isolated from amphibians
(Eisenberg et al., 2012; Fischer et al., 2012). The bacteria are
transmitted from animals to human by ingestion of infected
food products (meat or raw milk), direct contact with infected
animals or their tissues, or inhalation of aerosols. Humans
are accidental hosts, but brucellosis continues to be a major
public health concern worldwide and is the most widespread
zoonotic infection.
Brucella genus does not exhibit classic virulence factors,
such as exotoxins, exoproteases, cytolysins, or other exoenzymes
(Moreno and Moriyon, 2002). Observed tissue harm is a result
of inflammatory immune responses through the activation of
host immune responses after recognition of brucellar antigens
by immune receptors, such as Toll-like receptors (TLR) and
inflammasomes (Campos et al., 2004, 2017; Giambartolomei
et al., 2004; Zwerdling et al., 2008, 2009; García Samartino
et al., 2010; de Almeida et al., 2011, 2013; Delpino et al.,
2012; Gomes et al., 2013). Notwithstanding, with its intracellular
lifestyle, Brucella limits exposure to innate and adaptive immune
responses and leads the clinical manifestations of the disease and
pathology. Brucella takes advantage of intracellular destruction
by restringing fusion of Brucella-containing vacuoles with
lysosomal compartments in a mechanism mediated by the type
IV secretion system (T4SS) (Comerci et al., 2001). Also, Brucella
inhibits the apoptosis of infected macrophages and prevents
the development of adequate adaptive immune response by the
inhibition of antigen presentation (de Figueiredo et al., 2015;
Barrionuevo and Giambartolomei, 2019).
CLINICAL FEATURES OF BRUCELLA
LIVER INFECTION
The liver is the most commonly affected organ in patients with
active brucellosis. Accordingly, clinical and biochemical records
of liver involvement have been observed in up to 50% of patients
with active disease (Colmenero et al., 1996). Histopathological
analyses of liver biopsies from a large number of patients
with brucellosis have revealed liver parenchyma lesions due to
inflammation, including focal areas of cellular inflammation with
minimal necrosis of liver cells or the presence of granulomas with
different localizations in parenchymal tissue and portal space
(Akritidis et al., 2007). The pathology report on liver granulomas
in Brucella infection usually shows necrotizing granulomas with
a peripheral halo of epithelioid cells, lymphocytes, and plasma
cells, as well as polymorphonuclear infiltrate in the necrotic
area (Colmenero Jde et al., 2002; Villar et al., 2002). There are
differences in the histological evaluation of livermanifestations in
human brucellosis due to several causes. One of them is that most
reports are retrospective and lack bacteriological confirmation.
Also, previous reports with bacteriological confirmation did not
always specify the species of Brucella involved. Moreover, not
all of them used the same criteria to define granuloma (for
example, presence of epithelioid cells or presence of giant cells)
(Adams, 1976).
Liver biopsies also presented evidence of hepatitis (Akritidis
et al., 2007). The liver conducts the metabolism of carbohydrates,
proteins, and fats. Some of the enzymes and the end products
of these metabolic pathways may be utilized as biochemical
markers of liver dysfunction because they are very sensitive to
any abnormality that takes place. Despite the abovementioned,
the liver function is frequently normal in Brucella-infected
individuals. The total serum bilirubin may be slightly increased,
and the total serum protein, albumin, and globulin are usually
normal. The most frequent abnormalities are shown by the
increase in transaminases and alkaline phosphatase, although
they are non-specific (Young, 1995; Madkour, 2001). In these
patients, the presence of inflammatory infiltrates is also common,
andmost of them present parenchymal necrosis (Madkour, 2001;
Akritidis et al., 2007).
THE LIVER AS AN IMMUNE ORGAN
The liver is usually regarded only as a non-immunological
organ involved mainly in metabolic, nutrient storage, and
detoxification activities. However, it is a member of the
immune system responsible for the production of acute-phase
proteins, chemokines, cytokines, complement proteins, and
it also carries diverse populations of resident immune cells
(O’Farrelly and Crispe, 1999; Crispe, 2009; Nemeth et al., 2009).
Notwithstanding, the spleen is the main critical mediator in the
clearance of blood pathogens, which overlaps with the function
of the liver (Robinson et al., 2016).
Lymphocyte populations are present in the parenchyma
and the portal tracts of the liver. These populations consist
of conventional and unconventional lymphocytes of innate
immunity, NKT and NK cells, as well as cells of the adaptive
immune system, T and B cells (Freitas-Lopes et al., 2017).
Resident antigen-presenting cells are also abundant in the liver.
These cells are able to capture antigens that enter through
the liver or are released by dead or infected hepatocytes. The
group of resident antigen-presenting cells comprises Kupffer
cells (members of the reticuloendothelial system) (Gale et al.,
1978), liver sinusoidal endothelial cells (LSEC) (a particular
type of vascular endothelial cells) (Steffan et al., 1986),
and dendritic cells (DC) (Prickett et al., 1988; Lau and
Thomson, 2003). The presence of these cells is essential for
the maintenance of liver tolerance in physiological conditions
(Robinson et al., 2016).
Kupffer cells are the liver resident macrophages that adhere
to sinusoidal endothelial cells inside the sinusoids (Smith, 2013).
This localization is adequate to perform its function as a
scavenger removing protein complexes, small particles, senescent
red blood cells, and cell debris from the portal blood via pattern
recognition receptors (PRRs) (Petrasek et al., 2012).
LSEC are specialized endothelial cells that by the absence
of diaphragm and lack of basement membrane are the most
permeable endothelial cells in the body. In physiological
conditions, these cells maintain hepatic stellate cell (HSC)
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quiescence inhibiting fibrosis development. These cells have a
high phagocytic capacity and the molecules that promote antigen
processing and presentation with efficacy similar to that of DC
(Steffan et al., 1986; Lohse et al., 1996; Knolle et al., 1999).
Resident hepatic DC are located around the central veins
and portal tracts. The presence of interleukin (IL)-10 and
transforming growth factor (TGF)-β secreted by Kupffer
and LSEC cells in the absence of infection provides a
microenvironment capable of generating tolerant resident DC.
The activation of these cells increases their capacity to migrate
via the space of Disse to the lymphatic vessels in the portal tracts
and then to the extrahepatic lymph nodes (Matsuno et al., 1996;
Kudo et al., 1997).
Additionally, HSC and hepatocytes contribute to the immune
homeostasis of the liver. Quiescent HSC exert immunoregulatory
roles secreting chemokines, chemokine receptors, macrophage
inflammatory proteins (MIPs), and TLR and also function as
antigen-presenting cells (Friedman, 2008; Hernandez-Gea and
Friedman, 2011). Hepatocytes can also participate as antigen-
presenting cells, but they do not express the costimulatory
molecules CD80 and CD86 (Bertolino et al., 1998). Therefore,
hepatocytes induce T-cell functional activation but fail to
promote survival (Bertolino et al., 1998). In addition, hepatocytes
can also express PD-L1 in response to interferon (IFN) of type
I and II with the consequent induction of T-cell apoptosis
contributing to liver tolerance (Mühlbauer et al., 2006). This
immunotolerant capacity of the liver is due to its structure,
with resident immune cells in constant stimulation and the
hepatic blood supply that creates a unique cytokine and
growth factor milieu. This microenvironment determines the
balance between tolerance and inflammation in the healthy
liver. The complex of cytokine milieu in adult liver, in the
absence of pathological inflammation, includes basal expression
of proinflammatory cytokines IL-15, IL-7, IL-2, IL-12, IFN-γ,
and the anti-inflammatory cytokines IL-10, IL-13, and TFG-β
(Golden-Mason et al., 2004; Kelly et al., 2006). The tolerogenic
environment is maintained by regulatory myeloid populations,
such as myeloid-derived suppressor cells (MDSC), that mediate
their suppressive activity through the production of IL-10 and
TGF-β (Gabrilovich and Nagaraj, 2009). The transmigration
of monocytes leads to MDSC differentiation and activation,
contributing to the immunoregulatory capacity of the liver
(Sander et al., 2010; Zimmermann et al., 2015). In particular,
the impact of IL-10 in Brucella persistence and establishment
of chronic infection through the modulation of macrophages
has been demonstrated previously by using IL-10-deficient mice
(Xavier et al., 2013).
Nevertheless, this immune tolerance, the hepatic immune
system is able to induce rapid and controlled responses to
pathogenic microorganisms and tumor cells (Robinson et al.,
2016). Accordingly, most of the microorganisms that reach the
liver through the blood are eliminated. Although the liver has
several mechanisms to resist and to eliminate infectious agents,
some of them, such as Brucella spp, take advantage of the
immunotolerant capacity of the liver to escape from the immune
response and persist in the host. Besides, because the liver is
the organ with the largest number of resident macrophages
(Heymann and Tacke, 2016), we can speculate that the liver
constitutes a place for Brucella persistence.
BRUCELLA AND HSC IN FIBROSIS
HSC reside in the liver between the hepatocytes and the
small blood vessels. These cells are characterized as containing
intracellular lipid droplets and protrusions that extend around
the blood vessels. During liver damage, these cells are activated
and secrete collagen with the formation of scar tissue, leading to
chronic fibrosis or cirrhosis (Xu et al., 2012).
Brucella is an infectious stimulus that causes HSC
activation that involves the conversion of quiescent cells into
myofibroblasts, as revealed by the increase in α-smooth muscle
actin (SMA) expression, the increase in collagen secretion, the
inhibition of matrix metalloproteinase (MMP)-9 secretion, the
induction of the tissue inhibitor of metalloproteinases (TIMP)-1,
and the secretion of the master regulator of fibrosis TGF-β
(Arriola Benitez et al., 2013). TGF-β was identified as a main
driver of HSC activation, and several approaches targeting
the TGF-β signaling pathway were successfully used to engage
fibrosis in animal models of chronic liver diseases (Dooley and
ten Dijke, 2012; Puche et al., 2013).
HSC secrete the chemokines IL-8 and the monocyte
chemotactic protein (MCP)-1 in response to Brucella abortus
infection that could attract to the site of infection, neutrophils
and monocytes, respectively (Arriola Benitez et al., 2013). It
has been demonstrated that B. abortus-infected monocytes
could not reverse the fibrotic phenotype in B. abortus-infected
HSC. However, B. abortus-infected monocytes inhibit collagen
deposition and induce MMP-9 secretion in uninfected HSC
(Arriola Benitez et al., 2013). This may explain, at least in
part, why many patients with brucellosis have an inflammatory
infiltrate, but only some of them develop cirrhosis. Moreover,
in patients with brucellosis and cirrhosis, other causes such as
viral hepatitis or alcoholic cirrhosis, have not been ruled out
(Madkour, 2001).
Until now, it is unclear that Brucella infection can directly
or indirectly modulate HSC activity and, consequently, the
deposition of extracellular matrix. As in other liver diseases,
HSC activation during B. abortus infection could contribute
to granuloma formation by laying down a ring of collagen to
encapsulate the granuloma (Chuah et al., 2014) (Figure 1).
BRUCELLA TYPE IV SECRETION SYSTEM
IN FIBROSIS
T4SSs are amultiprotein complex involved in the translocation of
nucleoproteins and/or protein substrates across the bacterial cell
envelope to the host cell (Zechner et al., 2012). In Brucella, T4SS is
encoded by the virB operon, which consists of 12 genes (virB1-12)
located on chromosome II. The transcription of the virB operon
is controlled by the promoter upstream of virB1 (O’Callaghan
et al., 1999; Sieira et al., 2000). T4SS protein substrates have
been shown to modulate several cellular processes in the host
cell, such as apoptosis, vesicle trafficking, ubiquitination, and
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FIGURE 1 | Brucella abortus infection modulates the activation of hepatic stellate cells (HSC). (1) HSC secrete monocyte chemotactic protein (MCP)-1 and interleukin
(IL)-8 (chemoattractant of monocytes and neutrophils, respectively) in response to B. abortus infection. (2) Resident macrophages or monocytes attracted to the site
of infection could be infected by B. abortus and then modulate the expression of collagen and MMP-9 depending on the status of HSC (infected or not). In
non-infected HSC, B. abortus-infected monocytes induce an inflammatory phenotype characterized by the increase in MMP-9 expression and the inhibition of
collagen deposition. In contrast, B. abortus-infected monocytes induce the inhibition of matrix metalloproteinase (MMP)-9 secretion and the increase in collagen
deposition in infected HSC. (3) B. abortus infection of HSC induces HSC activation by inducing a fibrotic phenotype characterized by the expression of α-smooth
muscle actin (α-SMA), collagen deposition, and inhibition of MMP-9 through a mechanism that is dependent on the increase in transforming growth factor (TGF)-β and
tissue inhibitor of metalloproteinase (TIMP)-1. (4) Fibrosis induction by B. abortus infection was dependent on the Type IV secretion system (T4SS) and its secreted
effector BPE005 in a mechanism that depends on the cyclic AMP (cAMP)/protein kinase A (PKA) signaling pathway. (5) Fibrosis induction is also dependent on
autophagy pathway induction characterized by the increase in the expression of LC3II and Beclin-1 and the inhibition of p62 expression. (6) Then, B. abortus infection
induces cell death by apoptosis of activated HSC in a mechanism that is dependent on a functional T4SS and caspase 3 cleavage.
so on (Ninio and Roy, 2007; Franco et al., 2009). In Brucella,
T4SS has been shown to be involved in the modulation of
the immune system during infection (Roux et al., 2007; Rolán
and Tsolis, 2008; Gomes et al., 2013); Brucella protein effector
(BPE)005 is particularly involved in liver fibrosis (Arriola Benitez
et al., 2016). The predicted structure BPE005 suggests that it
might have an effect on cyclic AMP (cAMP) signaling pathways
(Marchesini et al., 2011). In the HSC, BPE005 may mediate
its effect by blocking the binding between cAMP and protein
kinase A (PKA) with the concomitant fibrosis induction, as
demonstrated in studies performed in vitro (Arriola Benitez et al.,
2016). Interestingly, the role of BPE005 in the modulation of
the fibrotic phenotype during B. abortus infection was confirmed
in an in vivo model in mice infected with a B. abortus BPE005
mutant. The histological analysis by Masson’s trichrome staining
revealed that the level of fibrotic patches is lower in mice
infected with BPE005 mutants than in those infected with the
wild-type counterpart. Accordingly, levels of collagen and TGF-
β were lower in mice infected with the B. abortus BPE005
mutant (Arriola Benitez et al., 2016).
The role of the cAMP/PKA signaling pathway in the
liver has been reported previously. The involvement of this
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pathway was demonstrated in various metabolic functions with
the main effect in the facilitation of carbohydrate and lipid
metabolism. cAMP plays a major role in the modulation of
the HSC function by inhibiting profibrogenic pathways in HSC
(Lopez-Sanchez et al., 2014).
Autophagy is involved in the fibrotic response during chronic
hepatic lesion caused by hepatitis virus infection, alcohol abuse,
and nonalcoholic steatohepatitis (Song et al., 2014).
Autophagy is a catabolic intracellular pathway that targets
defective or excessive organelles to the lysosomes for degradation
into amino acids, free fatty acids, or other small molecules used
for material recycling or energy harvesting (Mao and Fan, 2015).
Autophagy, usually stimulated by energy restriction, stress, or
inflammation, is regarded as a survival mechanism that plays
a critical role in maintaining cellular homeostasis, which is
involved in many human disorders, such as fibrotic disease (Yin
et al., 2008). In fibrosis, autophagy is mostly a cell survival
mechanism that attenuates hepatic inflammatory injury and
ultimately induces liver fibrosis (Mao and Fan, 2015). In addition,
and supporting the role of BPE005 in the induction of HSC
activation to a fibrotic phenotype, it has been demonstrated that
autophagy is involved in the fibrotic response due to B. abortus,
which depends on a functional T4SS and its effector BPE005
(Arriola Benitez et al., 2018). Autophagy was revealed by the
upregulation of the LC3II/LC3I ratio and Beclin-1 expression
and by the inhibition of p62 expression in infected cells (Arriola
Benitez et al., 2018). However, further studies are necessary to
determine if BPE005 could be a therapeutic target because this
factor induces a fibrogenic phenotype that could help not only
the host in the response to the inflammatory damage but also
in the formation of granulomas likely favoring the persistence
of bacterium.
Of note, the presence of liver cirrhosis during hepatic
brucellosis is a debatable issue (Madkour, 2001). In addition,
in murine models, cirrhosis was not observed upon infection
with B. abortus (Arriola Benitez et al., 2013). In line with
previous observations, B. abortus infection induces the clearance
of activated HSC by apoptosis through a mechanism that is
dependent on a functional T4SS and involved caspase 3 cleavage,
triggering the recovery of liver fibrosis (Arriola Benitez et al.,
2018) (Figure 1).
BRUCELLA AND HEPATOCYTES
Hepatocytes are the main cells of the liver parenchyma tissue
and occupy around 70–85% of the liver volume (Kmieć, 2001).
Hepatocytes are known to be involved in the synthesis of
proteins, glycoproteins, cholesterol, bile salts, and phospholipids.
On the other hand, they contribute to the detoxification and
excretion of substances. However, these cells also participate in
the immune response against pathogens. Hepatocytes respond
to viral, bacterial, and parasitic infections by secreting pro-
inflammatory cytokines and chemokines as mentioned elsewhere
(Santos et al., 2005; McCord et al., 2006; Costa et al., 2008;
Heydtmann and Adams, 2009), and B. abortus is not the
exception. B. abortus infects hepatocytes and induces the
secretion of IL-8, the main chemoattractant for neutrophil
(Delpino et al., 2010), which correlates with the neutrophil
infiltration observed in the liver of Brucella-infected patients
(Hunt and Bothwell, 1967; Colmenero Jde et al., 2002). B. abortus
infection also induces intercellular adhesion molecule (ICAM-
1) and MMP-9 secretion by hepatocytes (Delpino et al., 2010).
These molecules ensure the influx of neutrophils to the tissues.
ICAM-1 could facilitate the interaction of hepatocytes with
neutrophils, and MMP-9 promotes neutrophil transmigration
through degradation of extracellular matrix. These neutrophils
could be also infected by B. abortus, and in response to this
infection, they can contribute to the inflammatory reaction
through the secretion of IL-8 and MMP-9 by inducing the
expression of ICAM-1 by hepatocytes (Delpino et al., 2010).
Presence of liver parenchymal necrosis has been demonstrated
in patients with hepatic manifestations of brucellosis (Akritidis
et al., 2007), and hepatocytes occupy most of the parenchymal
tissue. The analysis of the effects of B. abortus infection
on hepatocyte viability revealed the induction of cell death
by apoptosis and cytotoxic release of lactate dehydrogenase
(LDH) in a T4SS-dependent manner (Delpino et al., 2010).
Neutrophils also contribute to the induction of apoptosis and
LDH release by hepatocytes as revealed by the stimulation
with culture supernatants from B. abortus-infected neutrophils
(Delpino et al., 2010).
B. abortus-infected hepatocytes can also modulate HSC
function. Supernatants from B. abortus-infected hepatocytes
induce MMP-9 secretion and inhibit collagen deposition in LX-
2 cells (Arriola Benitez et al., 2013). However, when stimulation
was performed on B. abortus-infected HSC, supernatants from
B. abortus-infected hepatocytes were unable to reverse the
inhibitory effect of B. abortus infection in the inhibition of MMP-
9 secretion and the induction of collagen deposition on HSC
(Arriola Benitez et al., 2013). The status of HSC (infected or not)
defines if B. abortus-infected hepatocytes induce a fibrotic or an
inflammatory phenotype in these cells (Figure 2).
IN VIVO STUDIES FOR LIVER
BRUCELLOSIS
The absence of a suitable animal model that can reproduce,
after experimental infection, the variety of disease manifestations
of human brucellosis has determined the slow progress in
most of the pathobiology of focal forms of the disease.
However, while laboratory rodents do not mimic all of the
spectrum of clinical signs and symptoms of human disease,
there are focal manifestations of liver brucellosis (Olsen
and Palmer, 2014). This allows characterizing at least in
part, the pathophysiological and immune manifestations of
hepatic brucellosis.
Studies performed in mice infected with Brucella melitensis
stated that most of the infected cells in the liver expressed
F4/80 myeloid marker. In the peak of infection, granuloma
formation occurs. Granulomas aremainly composed by CD11b+
F4/80+ MHC-II+ cells expressing iNOS/NOS2 enzyme (Copin
et al., 2012). A population of these cells also expressed
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FIGURE 2 | Response of hepatocytes to Brucella abortus infection. (1) B. abortus infection of hepatocyte induces the secretion of matrix metalloproteinase (MMP)-9
and interleukin (IL)-8 (chemoattractant of neutrophils) and increases the surface expression of intercellular adhesion molecule (ICAM)-1 and cell death by apoptosis. (2)
B. abortus-infected neutrophils secrete IL-8 and MMP-9 and induce the expression of ICAM-1 on hepatocytes. (3) HSC also interact with hepatocytes, and its
response is dependent on the status of HSC (infected or not). In non-infected HSC, B. abortus-infected hepatocytes induce an inflammatory phenotype characterized
by the increase in MMP-9 expression and the inhibition of collagen deposition. In contrast, B. abortus-infected hepatocytes induce the inhibition of MMP-9 secretion
and the increase in collagen deposition in infected HSC.
CD11c marker, indicating the presence of inflammatory
DC. However, further analyses are necessary to determine
if Brucella will remain in these cells or will migrate to
others that protect them from the immune response (Copin
et al., 2012). The delay in conducting these studies is due
to the fact that the murine model does not represent all
of the clinical manifestations of the disease, and that the
liver biopsy is not a medical practice for the diagnosis
of brucellosis.
In vivo studies also revealed that IL-10 production by
CD25+CD4+ T cells that modulate macrophage function
enhances bacterial survival and persistence in liver through
the modulation of the balance between pro-inflammatory and
anti-inflammatory cytokines (Xavier et al., 2013). In addition,
liver histopatology from infected IL-10−/− mice at 3 weeks
revealed multifocal granulomas and liver necrosis, as occurs in
wild-type mice. However, at 6 weeks postinfection, the number
of granulomas was reduced in IL-10−/− mice with respect
to wild-type controls. This reduction in liver pathology was
accompanied by the increase of CD4+CD25+ foxp3+ T cells with
the expression of TGF-β (Corsetti et al., 2013). We can speculate
that this reduction in liver pathology despite the increase in TGF-
β can be attributed to the reduction of bacterial number and the
consequent reduction in liver damage. However, further studies
would be necessary to determine if the TGF-β levels produced are
capable of causing liver fibrosis in these mice.
In addition, intraperitoneal infection of mice with B. abortus
allows corroborating in vitro findings, among them the role of
BPE005 in the induction of liver fibrosis revealed by the increase
in collagen deposition in liver and the expression of TGF-β
in HSC, as well as the presence of lymphocytic inflammatory
infiltrate (Arriola Benitez et al., 2013, 2016).
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Despite the limitations of the rodent model, it allowed to
corroborate the most relevant in vitro findings related to human
clinical outcomes.
CONCLUDING REMARKS
Liver involvement in active brucellosis has ranged from 5 to 52%
or more (Madkour, 2001). While the clinical and imaging aspect
of hepatic brucellosis has been widely described, the molecular
and cellularmechanisms involved in the damage and the immune
response in the liver have only been partially clarified over the
past 10 years. The findings summarized in this review attempt
to answer the key questions about the soluble mediators, local
and infiltrating cells involved in inflammatory damage during
liver brucellosis.
The infection through the T4SS effector, BPE005, could
modulate HSC activation to control the fibrotic process. It is
likely that BPE005 could participate in granuloma formation that
might act as a reservoir of bacteria contributing to the disease
chronicity. Additionally, and in line with the presence of liver
parenchymal necrosis observed in patients (Akritidis et al., 2007),
B. abortus induces cell death of hepatocytes in a mechanism
that also depends on a functional T4SS (Arriola Benitez et al.,
2018). Altogether, this knowledge could frame the first approach
toward the discovery of a new therapeutic target leading to new
treatments that could be coadministrated with antibiotics aimed
at reducing liver damage.
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